parkinson glutathione oxidative ipsc crispr Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease Frontiers | Development of CRISPR
Frontiers Development of CRISPR Cas9, spin off technologies and their application in model construction and potential therapeutic methods of Parkinson's disease Oxidative stress monitoring in iPSC derived motor neurons using genetically encoded biosensors of H2O2 Scientific Reports Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 PMC Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration npj Parkinson's Disease
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



